NEUROD1 and small cell lung carcinoma: In addition, the expression of ASCL1 or NEUROD1 on immunohistochemistry, as biomarkers associated with BrMs, was associated with worse CNS outcomes in BrM-free SCLC patients at diagnosis [177].